Sarfraz Ahmad, Ph.D.
Dr. Ahmad is Director of Clinical Research at Gynecologic Oncology Department of Florida Hospital Cancer Institute (FHCI), Orlando. Before joining FHCI in 2002, he spent 10-years in research and teaching at Loyola University of Chicago and University of Illinois at Chicago’s Division of Hematology/Oncology, College of Medicine. He has trained several fellows, residents, medical students, and undergraduate research students during their research projects. He is also Professor of Medical Education at University of Central Florida College of Medicine and Clinical Professor at Florida State University College of Medicine, Orlando.
His current research focus is on the analysis of clinico-pathologic and surgical outcomes of gynecology / oncology patients and to understand the cellular/molecular mechanisms of cancer and related thromboembolic disorders. His investigations are also aimed towards the evaluation of novel treatment options (chemo/cellular therapies) for better management of hemato-oncologic patients. His past research interests focused on the anticoagulant, antithrombin, antiplatelet, and thrombolytic drug development for the management of hematologic and cardiovascular patients. In these various areas of biomedical research, Dr. Ahmad has published nearly 150 peer-reviewed scholarly research articles and book chapters, and over 325 scientific abstracts. He is a reviewer for several biomedical journals and has received several competitive research grants and national/international awards for his research accomplishments/contributions.